ALION TO SUPPORT U.S. CHEMICAL, BIOLOGICAL, AND NUCLEAR DEFENSE
WASHINGTON -- The evolving threat of chemical, biological, radiological, nuclear, and high-yield weapons (CBRNE) is a reality at home and abroad. Countering these threats requires rapid research and solution development to ensure the safety of our war fighters and of American citizens. Alion is pleased to announce that it will assist the Department of Defense with research and development against CBRNE weapons as the prime contractor on a potential $8.3 billion IDIQ contract vehicle. This work will be delivered through the Joint Program Executive Office for Chemical and Biological Defense’s (JPEO-CBD) Joint Enterprise Research, Development, Acquisition and Production/Procurement (JE-RDAP) omnibus contract.
This multi-award, 10-year contract allows for task and delivery orders to extend for up to five years after the expiration of the 10-year base ordering period. Work will include providing CBRNE defense systems, capabilities, equipment, supplies and material; radiological/nuclear defense systems; and information systems to the warfighter through November 1, 2027.
You have 0 item(s) in your cart